Gastrointestinal side effect profile due to the use of alendronate in the treatment of osteoporosis

Aki S., Eskiyurt N., Akarirmak U., Tuzun F., Eryavuz M., Alper S., ...Daha Fazla

YONSEI MEDICAL JOURNAL, cilt.44, sa.6, ss.961-967, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 6
  • Basım Tarihi: 2003
  • Doi Numarası: 10.3349/ymj.2003.44.6.961
  • Dergi Adı: YONSEI MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.961-967
  • İstanbul Üniversitesi Adresli: Hayır

Özet

The aim of our study was to evaluate the upper gastrointestinal (GI) tract side effect profile in 759 female patients that had taken alendronate (10 mg/day), for at least 6 months, for the treatment of osteoporosis, in relation to the safety of alendronate and the compliance of patients to its absorption rules.